For the Inventor, By the Inventor

Enter assignee name

China Pharmaceutical University

USPTO Granted Patents = 34

CIPO Patents = 1

EPO Patents = 9

Forward Citations = 23

Loading Chart...

Loading Chart...

169 inventors (with patents filed for the assignee):

Qidong You (10 out of 12 patents)

Xiaoke Guo (6 out of 8 patents)

Zhengyu Jiang (5 out of 5 patents)

4. Xiaoli Xu (5 out of 7 patents)

5. Mengchen Lu (4 out of 4 patents)

6. Wenlong Huang (3 out of 3 patents)

7. Can Zhang (2 out of 2 patents)

8. Lei Zhang (2 out of 13 patents)

9. Haiping Hao (2 out of 2 patents)

10. Haopeng Sun (2 out of 3 patents)

11. Hua Xiang (2 out of 2 patents)

12. Hong Xiao (2 out of 2 patents)

13. Yao Yao (2 out of 2 patents)

14. Xiaobo Li (2 out of 2 patents)

15. Qingjiang Liao (2 out of 2 patents)

34 patents: Sort by Forward Citations

1. 12492212 - Substituted pyrazolecarboxamides as sting activators (2025-12-09),

2. 12453731 - Aniline-based WDR5 protein-protein interaction inhibitor, and preparation method and use thereof (2025-10-28),

3. 12383535 - Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor (2025-08-12),

4. 12331058 - SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same (2025-06-17),

5. 12310944 - Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof (2025-05-27),

6. 12226476 - Helper epitope peptide and application thereof (2025-02-18),

7. 12144881 - Cosmetic composition containing α-mangostin, method for preparation, and uses thereof (2024-11-19),

8. 11970523 - Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof (2024-04-30),

9. 11905230 - Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament (2024-02-20),

10. 11773057 - Naphthalenesulfonamide compound, preparation method, and application (2023-10-03),

11. 11572359 - PARP/PI3K double-target inhibit containing pyridopyrimidine structure (2023-02-07),

12. 11541032 - Composition containing sumo inhibitor and application (2023-01-03),

13. 11504385 - Proteolysis targeting chimeric molecule, preparation method, and application (2022-11-22),

14. 11479545 - Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction (2022-10-25),

15. 11304926 - Application of transient receptor potential cation channel TRPV3 in developing drug for preventing or treating psoriasis (2022-04-19),

China Pharmaceutical University (CPU) is a key comprehensive university in Jiangsu Province, China. It is one of the earliest higher pharmaceutical institutes established in the People's Republic of China, with its origin attributed to 1936. CPU is known for its excellence in pharmaceutical education, research, and innovation. The university offers a wide range of undergraduate, postgraduate, and doctoral programs in pharmaceutical sciences, clinical pharmacy, traditional Chinese medicine, pharmaceutical engineering, and related fields. CPU is committed to cultivating skilled professionals, fostering scientific research, and contributing to the development of pharmaceutical industry and healthcare in China.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

34 Patents

#14 in Nanjing

#837 in China

#19,060 in the World

China Pharmaceutical University

Forward Citations = 23

169 inventors:

Qidong You (10 out of 12 patents)

Xiaoke Guo (6 out of 8 patents)

Zhengyu Jiang (5 out of 5 patents)

4. Xiaoli Xu (5 out of 7 patents)

5. Mengchen Lu (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…